Canada's health framework law holds key provisions for device companies
This article was originally published in Clinica
Executive Summary
Transparency, balancing risks and benefits and managing the regulation of innovative products: these are the main cornerstones of Canada's proposed new framework healthcare law. All three are also aspects that are driving medical device regulatory policy discussions in the EU, and the Canadian document is useful in terms of understanding developing regulatory trends which are increasingly putting patients and risks associated with healthcare services and products at the centre of decision-making.